Literature DB >> 6285449

Serological diagnosis of pertussis: IgM, IgA and IgG antibodies against Bordetella pertussis measured by enzyme-linked immunosorbent assay (ELISA).

M K Viljanen, O Ruuskanen, C Granberg, T T Salmi.   

Abstract

Igm, IgA and IgG antibodies against Bordetella pertussis were measured by enzyme-linked immunosorbent assay (ELISA) with an ultrasonicate of formalin-killed bacteria (a mixture of strains 1, 2 and 1, 2, 3) as antigen and disposable polystyrene 9-cuvette blocks as the solid phase. The specificity properties of the assay were assessed by an inhibition technique. Of the microbes tested, only B. parapertussis was able to cause a significant inhibition. In addition, IgM and IgA antibodies against B. pertussis were only found in some sporadic cases of respiratory infections caused by other microbes. Sera, nasal swabs and cough plates were received from 198 patients with suspected whooping-cough. ELISA determinations were mostly made from only one serum sample of each patient. Paired sera were studied only from the culture-positive infants under 3 months of age. The number of positive cultures was highest in group under 3 months of age (41%), where the frequency of positive ELISA was lowest (20%). The use of paired sera strikingly increased the number of ELISA-positive individuals in this youngest patient group. In later life, the relationship between these tests changed: isolation was positive in only about 10% of the patients, whereas 29-64% yielded positive titres in ELISA. This study shows that pertussis ELISA is a valuable aid in the rapid diagnosis of pertussis, particularly of the atypical forms of the disease which mostly are culture-negative.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6285449     DOI: 10.3109/inf.1982.14.issue-2.08

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  23 in total

1.  Prevalence of pertussis IgG antibodies in children in Palermo, Italy.

Authors:  T Stroffolini; A Giammanco; L De Crescenzo; F Lupo; V Nicosia; G Torres; A R Valenza; A Cascio; S Taormina; L Nisticò
Journal:  Infection       Date:  1989 Sep-Oct       Impact factor: 3.553

2.  Evaluation of serologic assays for diagnosis of whooping cough.

Authors:  G Granström; B Wretlind; C R Salenstedt; M Granström
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

Review 3.  Pertussis: the disease and new diagnostic methods.

Authors:  R L Friedman
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

Review 4.  Laboratory diagnosis of pertussis: state of the art in 1997.

Authors:  F M Müller; J E Hoppe; C H Wirsing von König
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

5.  Evaluation of culture, immunofluorescence, and serology for the diagnosis of pertussis.

Authors:  S A Halperin; R Bortolussi; A J Wort
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

6.  Development of a rapid diagnostic test for pertussis: direct detection of pertussis toxin in respiratory secretions.

Authors:  R L Friedman; S Paulaitis; J W McMillan
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

7.  Pertussis: epidemiology and control.

Authors:  A S Muller; J Leeuwenburg; D S Pratt
Journal:  Bull World Health Organ       Date:  1986       Impact factor: 9.408

8.  Yersinia specific immune complexes in the synovial fluid of patients with yersinia triggered reactive arthritis.

Authors:  R Lahesmaa-Rantala; K Granfors; H Isomäki; A Toivanen
Journal:  Ann Rheum Dis       Date:  1987-07       Impact factor: 19.103

9.  Antibody response to pertussis toxin in patients with clinical pertussis measured by enzyme-linked immunosorbent assay.

Authors:  G Zackrisson; I Krantz; T Lagergård; P Larsson; R Sekura; N Sigurs; J Taranger; B Trollfors
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-04       Impact factor: 3.267

10.  Mixed outbreak of Bordetella pertussis and Bordetella parapertussis infection in Finland.

Authors:  J Mertsola
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.